Joseph Gonzalez-Heydrich, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotic Disorders | 15 | 2024 | 3099 | 1.950 |
Why?
|
| Evoked Potentials, Auditory | 4 | 2019 | 515 | 1.470 |
Why?
|
| Methylphenidate | 5 | 2014 | 477 | 1.270 |
Why?
|
| Epilepsy | 12 | 2021 | 3276 | 1.160 |
Why?
|
| Schizophrenia | 8 | 2023 | 6838 | 1.150 |
Why?
|
| Central Nervous System Stimulants | 6 | 2014 | 1157 | 0.980 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 10 | 2014 | 3670 | 0.970 |
Why?
|
| DNA Copy Number Variations | 4 | 2022 | 2000 | 0.690 |
Why?
|
| Suicidal Ideation | 4 | 2018 | 1261 | 0.680 |
Why?
|
| Valproic Acid | 3 | 2008 | 441 | 0.670 |
Why?
|
| Propylamines | 2 | 2010 | 161 | 0.620 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2019 | 149 | 0.610 |
Why?
|
| Carbamazepine | 2 | 2006 | 224 | 0.520 |
Why?
|
| Risperidone | 3 | 2008 | 380 | 0.500 |
Why?
|
| Neurophysiology | 1 | 2015 | 142 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 342 | 0.470 |
Why?
|
| Child | 51 | 2024 | 78492 | 0.470 |
Why?
|
| Social Support | 5 | 2022 | 2118 | 0.450 |
Why?
|
| Adaptation, Psychological | 9 | 2021 | 2570 | 0.450 |
Why?
|
| Point Mutation | 1 | 2018 | 1600 | 0.440 |
Why?
|
| Amphetamine | 1 | 2014 | 224 | 0.430 |
Why?
|
| Suicide, Attempted | 3 | 2018 | 1232 | 0.430 |
Why?
|
| Adolescent | 42 | 2024 | 86278 | 0.420 |
Why?
|
| Adrenergic Uptake Inhibitors | 2 | 2010 | 185 | 0.400 |
Why?
|
| Anticonvulsants | 5 | 2010 | 1874 | 0.400 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 1494 | 0.390 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5717 | 0.380 |
Why?
|
| Antipsychotic Agents | 6 | 2011 | 3053 | 0.340 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2001 | 620 | 0.340 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2018 | 1470 | 0.340 |
Why?
|
| Rage | 1 | 2009 | 30 | 0.330 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1283 | 0.330 |
Why?
|
| Internet | 3 | 2010 | 3039 | 0.330 |
Why?
|
| Language | 1 | 2018 | 1488 | 0.320 |
Why?
|
| Aggression | 4 | 2007 | 739 | 0.320 |
Why?
|
| Movement Disorders | 1 | 2012 | 460 | 0.320 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 2885 | 0.310 |
Why?
|
| Pediatrics | 5 | 2009 | 3562 | 0.300 |
Why?
|
| Emotional Intelligence | 1 | 2009 | 135 | 0.290 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1420 | 0.290 |
Why?
|
| Psychotropic Drugs | 2 | 2012 | 879 | 0.290 |
Why?
|
| Mianserin | 1 | 2007 | 50 | 0.290 |
Why?
|
| Autistic Disorder | 1 | 2016 | 1195 | 0.270 |
Why?
|
| Pirenzepine | 2 | 2003 | 115 | 0.270 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 432 | 0.240 |
Why?
|
| Phobic Disorders | 1 | 2007 | 439 | 0.240 |
Why?
|
| Electroencephalography | 6 | 2019 | 6069 | 0.240 |
Why?
|
| Mental Disorders | 6 | 2022 | 6639 | 0.230 |
Why?
|
| Narration | 1 | 2006 | 212 | 0.230 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5748 | 0.230 |
Why?
|
| Fragile X Syndrome | 2 | 2017 | 114 | 0.230 |
Why?
|
| Child, Preschool | 17 | 2024 | 41390 | 0.230 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 1422 | 0.220 |
Why?
|
| Hydrocortisone | 3 | 2001 | 1792 | 0.220 |
Why?
|
| Seizures | 2 | 2007 | 2880 | 0.220 |
Why?
|
| Male | 40 | 2024 | 351420 | 0.210 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 406 | 0.210 |
Why?
|
| Humans | 69 | 2024 | 746630 | 0.210 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 409 | 0.200 |
Why?
|
| Somatosensory Disorders | 1 | 2022 | 48 | 0.200 |
Why?
|
| Depressive Disorder, Major | 2 | 2019 | 4687 | 0.200 |
Why?
|
| Hallucinations | 1 | 2024 | 358 | 0.190 |
Why?
|
| Risk | 3 | 2019 | 9522 | 0.190 |
Why?
|
| Acoustic Stimulation | 2 | 2016 | 1228 | 0.190 |
Why?
|
| Bipolar Disorder | 3 | 2008 | 5050 | 0.190 |
Why?
|
| Alanine Transaminase | 1 | 2003 | 591 | 0.190 |
Why?
|
| Self-Help Groups | 2 | 2001 | 185 | 0.180 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2001 | 360 | 0.180 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2021 | 302 | 0.170 |
Why?
|
| Receptors, Serotonin | 2 | 1991 | 206 | 0.170 |
Why?
|
| Organ Transplantation | 1 | 2010 | 1130 | 0.170 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 153 | 0.170 |
Why?
|
| Antimanic Agents | 1 | 2003 | 521 | 0.170 |
Why?
|
| Quarantine | 1 | 2021 | 169 | 0.170 |
Why?
|
| Child Abuse, Sexual | 1 | 2001 | 383 | 0.160 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2021 | 475 | 0.160 |
Why?
|
| Female | 36 | 2022 | 382450 | 0.160 |
Why?
|
| Depressive Disorder | 2 | 2015 | 3744 | 0.160 |
Why?
|
| Psychopharmacology | 1 | 2000 | 142 | 0.160 |
Why?
|
| Phenotype | 5 | 2021 | 16261 | 0.140 |
Why?
|
| Psychotherapy | 3 | 2015 | 1632 | 0.140 |
Why?
|
| Social Behavior Disorders | 1 | 2017 | 97 | 0.140 |
Why?
|
| Social Perception | 2 | 2017 | 424 | 0.140 |
Why?
|
| Writing | 1 | 1998 | 201 | 0.130 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 221 | 0.130 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 186 | 0.130 |
Why?
|
| Theory of Mind | 1 | 2017 | 89 | 0.130 |
Why?
|
| Drugs, Investigational | 1 | 2017 | 214 | 0.120 |
Why?
|
| Pituitary-Adrenal System | 2 | 1999 | 540 | 0.120 |
Why?
|
| User-Computer Interface | 4 | 2003 | 1407 | 0.120 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 476 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2015 | 5997 | 0.120 |
Why?
|
| Parents | 2 | 2006 | 3463 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2019 | 569 | 0.120 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 2867 | 0.120 |
Why?
|
| Software | 5 | 2010 | 4400 | 0.120 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 1999 | 686 | 0.120 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2000 | 1190 | 0.120 |
Why?
|
| Uncertainty | 1 | 2019 | 741 | 0.110 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 942 | 0.110 |
Why?
|
| Child Abuse | 1 | 2022 | 1052 | 0.110 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 934 | 0.100 |
Why?
|
| Baclofen | 1 | 2012 | 119 | 0.100 |
Why?
|
| Age of Onset | 1 | 2018 | 3249 | 0.100 |
Why?
|
| Drug Interactions | 2 | 2008 | 1417 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 1391 | 0.090 |
Why?
|
| Caregivers | 1 | 2022 | 2136 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2018 | 3959 | 0.090 |
Why?
|
| Child Behavior | 1 | 2016 | 840 | 0.090 |
Why?
|
| Models, Neurological | 2 | 2022 | 1748 | 0.090 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 1990 | 37 | 0.090 |
Why?
|
| Evoked Potentials | 1 | 2016 | 1008 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2022 | 9599 | 0.090 |
Why?
|
| Family | 1 | 2021 | 3157 | 0.090 |
Why?
|
| Severity of Illness Index | 5 | 2015 | 15555 | 0.090 |
Why?
|
| Caudate Nucleus | 1 | 1991 | 394 | 0.090 |
Why?
|
| Personality | 1 | 1993 | 545 | 0.090 |
Why?
|
| Adult | 15 | 2023 | 215192 | 0.090 |
Why?
|
| Comorbidity | 5 | 2017 | 10372 | 0.090 |
Why?
|
| Behavior | 1 | 2012 | 546 | 0.080 |
Why?
|
| Models, Psychological | 1 | 1993 | 803 | 0.080 |
Why?
|
| Nervous System | 1 | 2012 | 540 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2014 | 2390 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2018 | 5379 | 0.080 |
Why?
|
| Emotions | 2 | 2017 | 2671 | 0.080 |
Why?
|
| Vomiting | 1 | 1991 | 629 | 0.080 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 1141 | 0.080 |
Why?
|
| Liver | 1 | 2003 | 7382 | 0.080 |
Why?
|
| Retrospective Studies | 8 | 2014 | 78313 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 1999 | 2534 | 0.070 |
Why?
|
| Amphetamines | 1 | 2007 | 138 | 0.070 |
Why?
|
| Hyperkinesis | 1 | 2007 | 88 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6226 | 0.070 |
Why?
|
| Pain | 1 | 2022 | 4982 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 599 | 0.070 |
Why?
|
| Neurology | 1 | 2014 | 767 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2679 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12840 | 0.070 |
Why?
|
| Personality Assessment | 1 | 2008 | 644 | 0.070 |
Why?
|
| Pilot Projects | 5 | 2024 | 8378 | 0.070 |
Why?
|
| Intelligence Tests | 1 | 2007 | 497 | 0.070 |
Why?
|
| Gene Expression | 1 | 2018 | 7590 | 0.060 |
Why?
|
| Linear Models | 1 | 2015 | 5831 | 0.060 |
Why?
|
| Serotonin | 1 | 1990 | 1028 | 0.060 |
Why?
|
| Medical Records | 1 | 2010 | 1391 | 0.060 |
Why?
|
| Child Development | 1 | 2017 | 2251 | 0.060 |
Why?
|
| Computer Simulation | 2 | 1999 | 6148 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 2015 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2920 | 0.060 |
Why?
|
| Affective Symptoms | 1 | 2007 | 411 | 0.060 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 6939 | 0.060 |
Why?
|
| Genotype | 1 | 2018 | 12788 | 0.060 |
Why?
|
| Depression | 2 | 2014 | 7826 | 0.060 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2003 | 21 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 2846 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2017 | 63732 | 0.060 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2366 | 0.050 |
Why?
|
| Feasibility Studies | 3 | 2010 | 5096 | 0.050 |
Why?
|
| Attitude to Computers | 2 | 2001 | 199 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2022 | 40534 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2015 | 2244 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 1411 | 0.050 |
Why?
|
| Mutation | 3 | 2022 | 29627 | 0.050 |
Why?
|
| Psychiatry | 1 | 2014 | 1683 | 0.050 |
Why?
|
| Synapses | 1 | 1991 | 1738 | 0.050 |
Why?
|
| Models, Biological | 2 | 1999 | 9455 | 0.050 |
Why?
|
| Calpain | 1 | 2022 | 146 | 0.050 |
Why?
|
| Safety | 1 | 2006 | 1149 | 0.050 |
Why?
|
| Computers | 1 | 2003 | 590 | 0.050 |
Why?
|
| Benzodiazepines | 2 | 2003 | 1114 | 0.040 |
Why?
|
| Age Factors | 2 | 2007 | 18157 | 0.040 |
Why?
|
| Mothers | 2 | 2001 | 2160 | 0.040 |
Why?
|
| Parvalbumins | 1 | 2021 | 257 | 0.040 |
Why?
|
| Biomedical Technology | 1 | 2002 | 211 | 0.040 |
Why?
|
| Neurons | 2 | 2021 | 9292 | 0.040 |
Why?
|
| Psychopathology | 1 | 2022 | 417 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2015 | 53253 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2021 | 866 | 0.040 |
Why?
|
| Social Behavior | 2 | 2017 | 1122 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 1172 | 0.040 |
Why?
|
| Hypermedia | 1 | 1998 | 21 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4883 | 0.040 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2000 | 269 | 0.040 |
Why?
|
| Multimedia | 1 | 1998 | 74 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2024 | 23464 | 0.040 |
Why?
|
| Neocortex | 1 | 2021 | 409 | 0.040 |
Why?
|
| Body Weight | 1 | 2008 | 4606 | 0.040 |
Why?
|
| Child Behavior Disorders | 1 | 2002 | 799 | 0.040 |
Why?
|
| Brain | 3 | 2021 | 26597 | 0.030 |
Why?
|
| Cognition | 1 | 2014 | 6782 | 0.030 |
Why?
|
| Interneurons | 1 | 2021 | 582 | 0.030 |
Why?
|
| Mother-Child Relations | 1 | 2000 | 485 | 0.030 |
Why?
|
| Pancreatitis | 1 | 2003 | 1098 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12227 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2006 | 2844 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 1999 | 479 | 0.030 |
Why?
|
| Risk Factors | 4 | 2022 | 72447 | 0.030 |
Why?
|
| Disabled Children | 1 | 1998 | 248 | 0.030 |
Why?
|
| Renal Dialysis | 2 | 2002 | 1695 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10750 | 0.030 |
Why?
|
| Pedigree | 1 | 2022 | 4557 | 0.030 |
Why?
|
| Heart Defects, Congenital | 2 | 2001 | 4656 | 0.030 |
Why?
|
| Fetus | 1 | 2021 | 1882 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 1999 | 1267 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23154 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2002 | 1816 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2000 | 9124 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 2541 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2018 | 21693 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 57163 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 2 | 2002 | 2452 | 0.020 |
Why?
|
| Giardiasis | 1 | 1991 | 27 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2012 | 357 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2277 | 0.020 |
Why?
|
| Esophageal Achalasia | 1 | 1991 | 94 | 0.020 |
Why?
|
| Stomach Diseases | 1 | 1991 | 130 | 0.020 |
Why?
|
| Family Therapy | 1 | 1991 | 208 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2023 | 3478 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 3578 | 0.020 |
Why?
|
| Child, Hospitalized | 2 | 2002 | 180 | 0.020 |
Why?
|
| Serotonin Antagonists | 1 | 1990 | 145 | 0.020 |
Why?
|
| Gastric Emptying | 1 | 1991 | 237 | 0.020 |
Why?
|
| Personality Disorders | 1 | 1993 | 717 | 0.020 |
Why?
|
| Lod Score | 1 | 2008 | 597 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1991 | 2300 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2008 | 448 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 1991 | 745 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 1867 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2021 | 12767 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17445 | 0.020 |
Why?
|
| Siblings | 1 | 2008 | 819 | 0.010 |
Why?
|
| Huntington Disease | 1 | 1991 | 1133 | 0.010 |
Why?
|
| Reference Values | 1 | 1991 | 4879 | 0.010 |
Why?
|
| Learning | 1 | 1993 | 1719 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1990 | 1161 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1999 | 7815 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 2381 | 0.010 |
Why?
|
| Middle Aged | 4 | 2022 | 214618 | 0.010 |
Why?
|
| Binding Sites | 1 | 1991 | 6030 | 0.010 |
Why?
|
| Adolescent, Hospitalized | 1 | 2002 | 31 | 0.010 |
Why?
|
| Play and Playthings | 1 | 2002 | 82 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2606 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 166558 | 0.010 |
Why?
|
| Nerve Net | 1 | 1993 | 2212 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7945 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 25759 | 0.010 |
Why?
|
| Weight Gain | 2 | 2002 | 2315 | 0.010 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2001 | 107 | 0.010 |
Why?
|
| Self Disclosure | 1 | 2002 | 246 | 0.010 |
Why?
|
| Video Games | 1 | 2003 | 186 | 0.010 |
Why?
|
| Prolactin | 1 | 2002 | 629 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 8521 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 3647 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 35456 | 0.010 |
Why?
|
| Computer Graphics | 1 | 2001 | 347 | 0.010 |
Why?
|
| Appetite | 1 | 2001 | 253 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2001 | 385 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 35797 | 0.010 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2001 | 269 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 10096 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 19819 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2001 | 1054 | 0.010 |
Why?
|
| Forecasting | 1 | 2002 | 2907 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 38771 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2001 | 2281 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2001 | 2676 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 15386 | 0.010 |
Why?
|
| Boston | 1 | 2002 | 9213 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2002 | 2764 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 1999 | 1987 | 0.000 |
Why?
|
| Patient Satisfaction | 1 | 2001 | 3413 | 0.000 |
Why?
|
| Attitude of Health Personnel | 1 | 2001 | 3837 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1991 | 57586 | 0.000 |
Why?
|
| United States | 1 | 2012 | 70437 | 0.000 |
Why?
|
| Time Factors | 1 | 2001 | 39622 | 0.000 |
Why?
|
| Aged | 1 | 1991 | 164383 | 0.000 |
Why?
|